Squarepoint
COGT icon

Squarepoint’s Cogent Biosciences COGT Stock Holding History

Squarepoint’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$403K Buy
+12,601
New +$466K ﹤0.01% 3542
2026
Q2 		– Sell
-226,259
Closed -$8.71M – 4487
2026
Q1 		$8.71M Buy
226,259
+70,275
+45% +$2.59M 0.01% 1147
2025
Q4 		$5.54M Buy
+155,984
New +$4.38M 0.01% 1393
2025
Q3 		– Sell
-101,518
Closed -$729K – 4437
2025
Q2 		$729K Buy
+101,518
New +$563K ﹤0.01% 2934
2025
Q1 		– Sell
-128,799
Closed -$1M – 4696
2024
Q4 		$1M Buy
128,799
+117,939
+1,086% +$1.18M ﹤0.01% 3061
2024
Q3 		$117K Buy
+10,860
New +$106K ﹤0.01% 3839
2024
Q2 		– Sell
-16,843
Closed -$113K – 4135
2024
Q1 		$113K Buy
16,843
+566
+3% +$3.5K ﹤0.01% 3775
2023
Q4 		$95.7K Buy
+16,277
New +$125K ﹤0.01% 3760
2023
Q2 		– Sell
-25,958
Closed -$280K – 3621
2023
Q1 		$280K Sell
25,958
-37,192
-59% -$476K ﹤0.01% 2615
2022
Q4 		$730K Buy
+63,150
New +$783K ﹤0.01% 2048
2022
Q1 		– Sell
-10,475
Closed -$90K – 2916
2021
Q4 		$90K Buy
+10,475
New +$91.1K ﹤0.01% 2942
2021
Q2 		– Sell
-10,290
Closed -$90K – 3286
2021
Q1 		$90K Sell
10,290
-1,982
-16% -$19.1K ﹤0.01% 2920
2020
Q4 		$138K Sell
12,272
-12,067
-50% -$133K ﹤0.01% 2635
2020
Q3 		$228K Buy
+24,339
New +$254K ﹤0.01% 2002
2018
Q4 		– Sell
-4,850
Closed -$200K – 1978
2018
Q3 		$200K Buy
+4,850
New +$273K ﹤0.01% 1775

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Squarepoint's COGT Position: Q3 2026 in Review

Squarepoint opened a new position in Cogent Biosciences (COGT) in Q3 2026: 12,601 shares worth $403K. The stake represents ﹤0.01% of the portfolio and ranks #3542 among its holdings. This is a return to the name: Squarepoint previously reported a position in COGT as recently as Q1 2026.

Squarepoint first reported a position in COGT in Q3 2018 and has held it in 15 quarters since. The position peaked at $8.71M in Q1 2026. 151 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Squarepoint held 12,601 shares of Cogent Biosciences worth $403K as of Q3 2026.
  • Cogent Biosciences was a new Squarepoint position in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3542 holding.
  • Squarepoint first reported a position in Cogent Biosciences in Q3 2018 and has held it in 15 quarters since.
  • Squarepoint's Cogent Biosciences position peaked at $8.71M in Q1 2026.
  • 151 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.